SENSUS HEALTHCARE INC (SRTS) Stock News
NASDAQ:SRTS - Nasdaq - US81728J1097 - Common Stock - Currency: USD
SRTS Latest News, Press Relases and Analysis
Why Biohaven Stock Dove by Nearly 20% on Thursday
Volatile biotech stock Biohaven (NYSE: BHVN) is prone to sharp movements both up and down. After market close on Wednesday, Biohaven divulged that the U.S. Food and Drug Administration's (FDA) Division of Neurology 1 is extending the due date for its decision on a very promising pipeline drug developed by the company. Specifically, the FDA unit is extending the Prescription Drug User Fee Act (PDUFA) date for Biohaven's troriluzole, a treatment that targets brain disorder spinocerebellar ataxia (SCA), by three months.
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates
Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -500% and 14.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MLAB
Sensus Healthcare Reports First Quarter 2025 Financial Results
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of 14.29% and 10.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: DRIO
Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.22, marking a -0.47% move from the previous day.
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know
Sensus Healthcare, Inc. (SRTS) closed at $4.33 in the latest trading session, marking a +0.7% move from the prior day.
Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q1 Earnings Expected to Decline
Sensus Healthcare (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: WAT
Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15
Sensus Healthcare, Inc. (SRTS) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.69, marking a +1.3% move from the previous day.
Sensus Healthcare, Inc. (SRTS) Gains As Market Dips: What You Should Know
Sensus Healthcare, Inc. (SRTS) reachead $4.72 at the closing of the latest trading day, reflecting a +1.51% change compared to its last close.
Is Senseonics Holdings (SENS) the Best Penny Stock to Invest in Under $1?
We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look at where Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) stands against other penny stocks to invest in under $1. Earlier on February 12 this year, Chief Investment Officer at Cetera Financial Group, […]
Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.69, moving +1.08% from the previous trading session.
Sensus Healthcare to Participate in the 37th Annual ROTH Conference
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting
Sensus Healthcare Buys Back Shares
Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
Sensus Healthcare to Present at The Microcap Conference 2025
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration
Full-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic visits BOCA RATON, Fla,...
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration
REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and...
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter
Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative...
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,...